A new trading day began on Tuesday, with Revolution Medicines Inc (NASDAQ: RVMD) stock price up 1.05% from the previous day of trading, before settling in for the closing price of $43.93. RVMD’s price has ranged from $25.93 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 11.11%. Meanwhile, its annual earnings per share averaged 9.86%. With a float of $151.67 million, this company’s outstanding shares have now reached $167.75 million.
Let’s determine the extent of company efficiency that accounts for 378 employees. In terms of profitability, gross margin is -17912.67%, operating margin of -88031.94%, and the pretax margin is -76377.09%.
Revolution Medicines Inc (RVMD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 16.82%, while institutional ownership is 81.77%. The most recent insider transaction that took place on Dec 16 ’24, was worth 196,553. In this transaction Chief Operating Officer of this company sold 4,329 shares at a rate of $45.40, taking the stock ownership to the 127,991 shares. Before that another transaction happened on Dec 16 ’24, when Company’s insider sold 11,714 for $45.40, making the entire transaction worth $531,860. This insider now owns 325,056 shares in total.
Revolution Medicines Inc (RVMD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 9.86% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Here are Revolution Medicines Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10938.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.94 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Looking closely at Revolution Medicines Inc (NASDAQ: RVMD), its last 5-days average volume was 1.37 million, which is a drop from its year-to-date volume of 1.39 million. As of the previous 9 days, the stock’s Stochastic %D was 31.78%. Additionally, its Average True Range was 1.96.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 19.60%, which indicates a significant decrease from 28.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.28% in the past 14 days, which was lower than the 43.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.46, while its 200-day Moving Average is $43.03. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $44.71. Second resistance stands at $45.03. The third major resistance level sits at $45.64. If the price goes on to break the first support level at $43.78, it is likely to go to the next support level at $43.17. Now, if the price goes above the second support level, the third support stands at $42.85.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
With a market capitalization of 8.09 billion, the company has a total of 168,219K Shares Outstanding. Currently, annual sales are 11,580 K while annual income is -436,370 K. The company’s previous quarter sales were 0 K while its latest quarter income was -156,290 K.
